As of 2024-12-14, the Intrinsic Value of Diaceutics PLC (DXRX.L) is
78.49 GBP. This DXRX.L valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y).
With the current market price of 120.00 GBP, the upside of Diaceutics PLC is
-34.60%.
The range of the Intrinsic Value is 46.80 - 104.59 GBP
78.49 GBP
Intrinsic Value
DXRX.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(1,248.49) - (164.81) |
(292.52) |
-343.8% |
| DCF (Growth 10y) |
(175.20) - (1,203.84) |
(297.12) |
-347.6% |
| DCF (EBITDA 5y) |
46.80 - 104.59 |
78.49 |
-34.6% |
| DCF (EBITDA 10y) |
43.21 - 138.40 |
93.10 |
-22.4% |
| Fair Value |
-16.77 - -16.77 |
-16.77 |
-113.97% |
| P/E |
(80.15) - (121.46) |
(122.40) |
-202.0% |
| EV/EBITDA |
49.03 - 167.90 |
106.36 |
-11.4% |
| EPV |
(34.11) - (50.54) |
(42.32) |
-135.3% |
| DDM - Stable |
(54.63) - (500.32) |
(277.48) |
-331.2% |
| DDM - Multi |
(39.75) - (281.21) |
(69.49) |
-157.9% |
DXRX.L Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
101.81 |
| Beta |
-0.19 |
| Outstanding shares (mil) |
0.85 |
| Enterprise Value (mil) |
86.19 |
| Market risk premium |
5.98% |
| Cost of Equity |
6.45% |
| Cost of Debt |
8.80% |
| WACC |
6.45% |